A newly discovered link between pancreatic cancer and neural signaling reveals a promising drug target that slows tumor growth by blocking glutamate uptake. Pancreatic cancer is among the most deadly cancers, and scientists are still working to understand what drives its aggressive behavior. A research team at the Technical University of Munich (TUM) has identified […]
Source link